improves the life of patients with malignant diseases through targeted molecular diagnostic and therapy
| Website | http://www.pentixapharm.com |
| Revenue | $5.5 million |
| Employees | 37 (30 on RocketReach) |
| Founded | 2019 |
| Industry | Pharmaceutical Manufacturing, Biotechnology, Drug Discovery |
| Keywords | Molecular Diagnostics, Cancer Diagnostics, Targeted Therapy, Oncology Diagnostics, Cancer Therapeutics, Precision Oncology, Biomarker Discovery, Molecular Medicine, Drug Development, Pharmaceutical Research, Diagnostic Testing, Clinical Trials, Therapeutic Solutions, Patient Care, Healthcare Solutions, Medical Technology, Life Sciences, Biotechnology, Pharmaceutical |
| Competitors | Siemens Healthineers, GE HealthCare, Bayer, Philips, Cardinal Health, Elekta, abcam, CureVac, Radiomedix, Inc., Meditech Home Health Inc +39 more (view full list) |
Looking for a particular PentixaPharm GmbH employee's phone or email?
The PentixaPharm GmbH annual revenue was $5.5 million in 2026.
Erik Merten is the CTO of PentixaPharm GmbH.
30 people are employed at PentixaPharm GmbH.